Faster peritoneal transport has been associated with an increased risk of therapy failure and patient mortality. However, faster transport can the result of many factors. Peritoneal protein clearance (PPC) has been proposed to distinguish faster peritoneal transport attributable to inflammatory conditions, as protein clearance reflects large-pore flow, which increases during inflammation. We followed a cohort of 300 peritoneal dialysis patients, and after adjustments for age and comorbidity, higher PPC was associated with increased risk of death (hazard ratio: 1.81; 95% confidence interval: 1.11 to 2.95), even after patients underwent transplantation or transferred to hemodialysis.
BrimbleK.S., WalkerM., MargettsP.J., KundhalK.K., RabbatC.G.Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis.J Am Soc Nephrol2006; 17: 2591–8.
2.
JohnsonD.W., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.Nephrol Dial Transplant2010; 25: 1973–9.
3.
DavenportA., WillicombeM.K.Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi-frequency bioimpedance.Int J Artif Organs2009; 32: 779–86.
4.
HeafJ.G.Peritoneal transport: getting more complicated.Nephrol Dial Transplant2012; 27: 4248–51.
5.
HeafJ.G., SaracS., AfzalS.A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients.Nephrol Dial Transplant2005; 20: 2194–201.
6.
PerlJ., HuckvaleK., ChellarM., JohnB., DaviesS.J.Peritoneal protein clearance and not peritoneal membrane transport status predicts survival in a contemporary cohort of peritoneal dialysis patients.Clin J Am Soc Nephrol2009; 4: 1201–6.
7.
BalafaO., HalbesmaN., StruijkD.G., DekkerF.W., KredietR.T.Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients.Clin J Am Soc Nephrol2011; 6: 561–6.
TwardowskiZ.J.PET—a simpler approach for determining prescriptions for adequate dialysis therapy.Adv Perit Dial1990; 6: 186–91.
10.
WatsonP.E., WatsonI.D., BattR.D.Total body water volumes for adult males and females estimated from simple anthropometric measurements.Am J Clin Nutr1980; 33: 27–39.
11.
Du BoisD., Du BoisE.F.A formula to estimate the approximate surface area if height and weight be known.Arch Intern Med1916; 17: 863–71.
12.
PapakrivopoulouE., BoothJ., PinneyJ., DavenportA.Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients.Nephron Extra2012; 2: 48–54.
13.
DavenportA., WillicombeM.Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi-frequency bioimpedance.Int J Artif Organs2009; 32: 779–86.
14.
DavenportA.Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients.Am J Nephrol2012; 36: 371–6.
15.
DaviesS.J.Assessment of comorbidity in peritoneal dialysis patients.Contrib Nephrol2003;: 98–103.
16.
Pérez–FontánM., Rodríguez–CarmonaA., BarredaD., López–MuñizA., Blanco–CastroN., García–FalcónT.Peritoneal protein transport during the baseline peritoneal equilibration test is an accurate predictor of the outcome of peritoneal dialysis patients.Nephron Clin Pract2010; 116: c104–13.
17.
DavenportA., SayedR.H., FanS.Is extracellular volume expansion of peritoneal dialysis patients associated with greater urine output?Blood Purif2011; 32: 226–31.
18.
DavenportA., WillicombeM.K.Hydration status does not influence peritoneal equilibration test ultrafiltration volumes.Clin J Am Soc Nephrol2009; 4: 1207–12.
19.
PapakrivopoulouE., LillywhiteS., DavenportA.Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?Nephrol Dial Transplant2012; 27: 396–401.
